Frontiers in Immunology (Jan 2021)

SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response

  • Jackson S. Turner,
  • Aaron Day,
  • Wafaa B. Alsoussi,
  • Zhuoming Liu,
  • Jane A. O’Halloran,
  • Rachel M. Presti,
  • Bruce K. Patterson,
  • Sean P. J. Whelan,
  • Ali H. Ellebedy,
  • Philip A. Mudd

DOI
https://doi.org/10.3389/fimmu.2020.618402
Journal volume & issue
Vol. 11

Abstract

Read online

Prolonged shedding of viral RNA occurs in some individuals following SARS-CoV-2 infection. We perform comprehensive immunologic evaluation of one individual with prolonged shedding. The case subject recovered from severe COVID-19 and tested positive for SARS-CoV-2 viral RNA repeatedly as many as 87 days after the first positive test, 97 days after symptom onset. The subject did not have any associated rise in anti-Spike protein antibody titers or plasma neutralization activity, arguing against re-infection. This index subject exhibited a profoundly diminished circulating CD8+ T cell population and correspondingly low SARS-CoV-2-specific CD8+ T cell responses when compared with a cohort of other recovering COVID-19 subjects. CD4+ T cell responses and neutralizing antibody responses developed as expected in this individual. Our results demonstrate that detectable viral RNA shedding in the upper airway can occur more than 3 months following infection in some individuals with COVID-19 and suggest that impaired CD8+ T cells may play a role in prolonged viral RNA shedding.

Keywords